Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
21m
EU regulator backs use of Novo's Wegovy for obesity related heart condition
Novo's US rival Eli Lilly's drug tirzepatide is also approved for weight loss in the EU. Tirzepatide has shown to cut heart ...
50m
Novo Nordisk's Wegovy Recommended For Label Update To Reflect Heart Failure Benefits
Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Makes MLB history
COVID, Wuhan market link
Boy kills bear, saves father
Rally attendees injured
Ban called for in TX schools
To get a second moon
Families lose appeal
Gun case sentencing delay
To receive Holbrooke award
30 yrs in prison for assault
Man charged for threats
NYC subway joyride arrest
Joins Motion Picture Assn.
Dow, S&P hit record highs
Brazil threatens daily fines
Sets new WNBA record
AC mayor, wife indicted
Retires after 17 seasons
Hails economic progress
FTC on privacy controls
US healthcare system falls
EU warns Apple
Israel strikes Hezbollah
160M euros to Ukraine
Deal to build new arena
Los Angeles dengue cases
Existing home sales drop
Launches AI assistant
Retaliated against scientists
New SEC stock pricing rule
Cancer deaths decline
Related topics
Novo Nordisk
Ozempic
Amycretin
Feedback